Moreover, retinoid signaling has been reported to downregulate key EMT‐associated transcription factors—many of which overlap with PHLDA1 downstream effectors—thereby providing a mechanistic rationale for TTNPB’s potential efficacy in disrupting CAF–tumor crosstalk. This evidence concerns the gene PHLDA1 and neoplasm.